Affordable Access

Rotigotine Schwarz Pharma.

Authors
  • Mucke, Hermann A M
Type
Published Article
Journal
IDrugs : the investigational drugs journal
Publication Date
Sep 01, 2003
Volume
6
Issue
9
Pages
894–899
Identifiers
PMID: 12964070
Source
Medline
License
Unknown

Abstract

Schwarz Pharma AG, under license from Aderis Pharmaceuticals Inc, is developing rotigotine CDS, a once-daily transdermal patch formulation of rotigotine, which is a naphthol-derived selective D(2) dopamine agonist, for the potential treatment of Parkinson's disease and restless legs syndrome.

Report this publication

Statistics

Seen <100 times